The neuroprotective potential of MIS416, a myeloid-directed innate immune therapeutic in Phase 2B trial for the treatment of secondary progressive multiple sclerosis

Gill Webster, Vicky Pearson, Edwin Lim, Nancy Mayo

    Research output: Contribution to journalMeeting abstractpeer-review

    Original languageEnglish
    Article numberPP1.27
    Pages (from-to)NP25
    Number of pages1
    JournalMultiple Sclerosis
    Issue number14
    Publication statusPublished - Dec 2015
    EventMS Research Australia Progress in MS Research Conference - Melbourne, Australia
    Duration: 29 Oct 201530 Oct 2015


    • Myeloid-directed
    • neuroprotection
    • kynurenine/tryptophan
    • growth-factors
    • anti-inflammatory

    Cite this